That question is the whole job, and in most organizations it takes three weeks and four people. Answering it means moving from a substance to the products containing it, to the presentations of those products, to the markets where each is registered, to the variations in flight against each registration, to the documents and labelling affected, to the commitments attached. That is a traversal across connected things. Regulatory information is a graph, and almost everybody stores it as lists.
We build the regulatory information layer for pharmaceutical, biotechnology and medical device organizations: product, substance and organisation master data that other objects can hang off, registration and licence tracking with dates and in-flight changes visible, submission planning and tracking, commitments managed as obligations with owners and deadlines, labelling information connected to the registrations it belongs to, and the structured product data work the standards in your roadmap imply. Your regulatory affairs function owns the regulatory positions, the submissions and the determinations. We make the information behind them answerable.
Most regulatory estates are good at storage and poor at connection. The submission archive is organised, the correspondence is filed, the registration certificates are where they should be. What is missing is the relationships: which presentations of this product exist, which markets each is registered in, which registration is due for renewal, which variation is pending where, which commitment arose from which interaction, which labelling version applies in which country, and what else moves if the manufacturing site changes. Each of those facts exists. None of them is connected to the others in a way a system can traverse.
So the characteristic regulatory question becomes a research project. A change is proposed, somebody is asked what it affects, and the answer is assembled from a registration spreadsheet one person maintains, a submission tracker another maintains, the knowledge of whoever has been in the department longest, and a careful reading of several PDFs. The answer is usually correct, arrives slowly, and cannot be reproduced or audited. It also quietly sets the organization’s risk appetite, because a team that cannot establish impact quickly will either delay changes it should make or make them without knowing the consequences.
The data is stored as lists and the questions are traversals
Which is why impact assessment takes weeks rather than minutes.
Product identity exists in three incompatible versions
Regulatory, manufacturing and commercial each have their own, and none maps to the others.
Commitments live in correspondence and a spreadsheet
The highest-consequence data in the estate with the least system support.
Registration status is recorded as a word
Approved, with no dates, no renewal horizon and no pending variation.
Labelling is managed separately from the registrations it belongs to
So nobody can say which version is approved in which market today.
Global requirements differ and the model assumes they do not
A system built for one region fails quietly in the next.
Global and local both think they own the record
So the central view is only as current as the least diligent affiliate update.
The person who knows is a single point of failure
And the organization has not noticed because they have always been there.
Ask the impact question cold and time it. Pick a plausible change, a manufacturing site, an excipient, a specification, a substance supplier, and ask the regulatory team which registrations, variations, documents, labelling versions and commitments would be affected. Then measure two things: how long the answer takes, and how many people had to be asked. The time is the obvious finding. The number of people is the important one, because it tells you how much of your regulatory information lives in individuals rather than in systems, and therefore what happens when one of them retires. The exercise costs an afternoon of somebody’s goodwill and it is the most honest assessment of a regulatory estate available.
The order is deliberate and the first four steps are where these programmes are won or lost. A RIM platform can be configured in weeks. Getting product, substance, presentation and organisation identity right is the actual project, and every object in the system hangs off it.
Step 1
Assess the questions the organization cannot answer
Step 2
Map the data model that answers them
Step 3
Standardize identity before anything else
Step 4
Govern the master data with named stewards
Step 5
Integrate with the systems that hold adjacent truth
Step 6
Migrate with a defined scope and a stated quality bar
Step 7
Validate to intended use
Step 8
Implement in sequence, by question answered
Step 9
Monitor completeness, deadlines and data quality
Step 10
Optimize and extend to structured product data
Define success as a question you can answer, not a module you can deploy. Regulatory programmes are commonly planned as a sequence of system modules and judged on go-live. A more useful plan sequences the questions: by the end of this release, the organization can state which registrations are affected by a substance change, in minutes, from the system, reproducibly. Then: what renews in the next eighteen months, by market. Then: every open commitment with its owner and due date. Each of those is testable, each is something somebody senior actually wants, and each forces exactly as much master data and integration work as it needs and no more. Module-based plans deliver capability nobody uses yet. Question-based plans deliver answers.
Grouped by what each capability makes answerable. Most organizations need the first group before the others are worth building, and most want to start with the third because that is where the pain is.
The foundation
Regulatory master data management for product, substance, presentation, organisation and site
Country, market and authority reference data, including procedure types and market structures
Duplicate detection and resolution, because duplicate product records defeat every impact query
Identity mapping to manufacturing, quality, labelling and commercial identifiers rather than replacing them
Stewardship model with named owners per master data domain and a change process
Data model design that supports traversal, so impact questions are queries rather than projects
Structured product and substance data readiness for the standards in your regulatory roadmap
Registrations and submissions
Product registration and licence tracking with effective dates, renewal horizon and pending changes
Submission planning and tracking across markets, with dependencies visible
eCTD and submission content coordination, including what is reused across markets
Variation and renewal management, including what else a change obliges you to do
Health authority correspondence captured as records connected to the registrations they concern
Obligations and content
Regulatory commitments management as objects with owners, deadlines, status and evidence
Regulatory document management connected to products, registrations and submissions
Labelling information management linked to the registrations and markets each version applies to
Change impact assessment support, driven by the data model rather than by recollection
Regulatory intelligence capture, so monitored requirements connect to affected registrations
Visibility and operation
Regulatory reporting and portfolio dashboards across markets, products and pipelines
Renewal and commitment deadline forecasting, with enough horizon to act on
Data completeness and quality monitoring against the model, continuously
RIM platform implementation, configuration, migration and integration
Validation evidence produced as a build deliverable, scoped to intended use
What looks like ten separate capabilities is largely one data model answering ten questions. That is the argument for building the model first, and it is also why organizations that buy a module at a time find each one less useful than expected.
| Use case | The question behind it | What it needs from the model |
|---|---|---|
| Global product registrations | What is approved where, as of today | Registrations with dates and conditions, not a status word |
| Marketing authorization applications | What is in flight and what it depends on | Submissions linked to planned registrations and to content reuse |
| Regulatory submissions | What has been filed, where, containing what | Submission records connected to documents and to the registration affected |
| Variations | What else does this change oblige us to do | Variations as events against a registration, with cascade visible |
| Renewals | What falls due in the next eighteen months | Effective and expiry dates, so the horizon is a query |
| Regulatory intelligence | Which of our products does this new requirement touch | Monitored requirements mapped to products and markets |
| Health authority interactions | What was agreed, and what did it commit us to | Correspondence as records, with commitments extracted and owned |
| Post-approval changes | What is the full impact across the portfolio | The traversal, which is the whole point of the model |
| Regulatory commitments | What is outstanding, owned by whom, due when | Commitments as objects rather than rows in a tracker |
| Product lifecycle management | What changes as a product ages or is withdrawn | Lifecycle state per market, with dependencies |
| Global portfolio oversight | Where is the regulatory risk concentrated | Aggregation across all of the above, which only works if the model holds |
This is the most expensive misunderstanding in RIM implementation. The platforms are capable and they ship with object structures, lifecycles and workflow that encode a great deal of sensible practice. What none of them can supply is the decision about what your products, presentations and substances are and how they map to the identifiers the rest of your organization uses. That is yours, it is the critical path, and no configuration effort substitutes for it.
| Layer | What belongs there | The constraint |
|---|---|---|
| Regulatory master data | Product, substance, presentation, organisation, site identity | Must be agreed cross-functionally before objects hang off it |
| RIM platform | Registrations, submissions, variations, commitments, lifecycles, workflow | Configuration encodes your model, so the model has to exist first |
| Document management | Submission content, correspondence, certificates, labelling artwork | Connected to products and registrations, not filed in parallel |
| Submission assembly | eCTD and market-specific publishing of compiled content | Format and validation rules differ by authority and change over time |
| Structured product data | Formal identified product and substance representations | Scope, applicable elements and timing are your regulatory determination |
| Enterprise integration | ERP, PLM, QMS and labelling as adjacent sources of truth | Each is authoritative for some fields and not for others |
| Reporting layer | Portfolio, renewal, commitment and completeness views | Only as good as the model underneath, which is the recurring theme |
Count how many places your product identity exists. Ask each function which identifier it uses for a given product and presentation, and whether a mapping to the others exists in a system or in somebody’s head. The usual answer is three or four identifier schemes, partial mappings maintained manually, and at least one pair with no mapping at all. That count is the best single predictor of how long a RIM programme will take, and establishing it costs a morning. It is also the argument that gets master data funded, because the finding is concrete in a way that an architecture diagram is not.
Regulatory information is distinctive in that much of it leaves the organization and is relied upon by an authority. A value that is wrong in a submission is a different class of problem from a value that is wrong in a report. Which frameworks apply, how a system is classified and what validation it requires are determined by your quality and regulatory functions, and so is the applicability of every standard named here.
Frameworks where they apply
- GxP and GAMP 5 risk-based lifecycle approaches where your quality function has adopted them
- FDA 21 CFR Part 11 and EU Annex 11 for electronic records and signatures where applicable
- ISO IDMP and EMA SPOR as structured product data standards, with scope determined by you
- Computerized system validation scoped to the intended use your quality function assigns
Records and signatures
- Electronic signatures implemented to the requirements your quality function specifies
- Audit trail capturing who changed what, when, from what value and for what stated reason
- Point-in-time reconstruction, so what a submission asserted can be evidenced later
- Controlled correction with no silent overwrite anywhere in the chain
Access
- Role-based access resolved per user, with market and product scope where required
- Separation where partners, licensees or distributors have visibility of part of the portfolio
- Least privilege for integration identities, scoped to the fields they move
- Export and download treated as part of the access model, because an export leaves it
Data quality
- Completeness measured against the model, so a missing attribute is visible as missing
- Validation rules at entry rather than discovery at submission assembly
- Stewardship with named owners per master data domain and a change process
- Change control over the model itself, since it determines what every object can express
- Assessment of changes to regulatory specifications and authority services, because those evolve and can oblige a controlled change to the model or the extracts
Regulatory dashboards overwhelmingly report current state: what is approved, what is submitted, what is pending. Current state is necessary and it is not actionable, because everything that requires action in this function has a date in the future attached to it.
| Failure | How it presents |
|---|---|
| A renewal approaches unseen | Status says approved, and nothing counts down |
| A commitment deadline passes | The obligation was in a spreadsheet one person maintained |
| A required attribute is empty | Discovered during submission assembly, under time pressure |
| Master data diverges | Two functions update the same real-world thing differently and both are confident |
| A variation is tracked apart from its registration | The registration view is current and the pending change is invisible from it |
| Labelling drifts from the registration | Nobody can state which version is approved in which market today |
| An intelligence update is never connected | The requirement changed, somebody read it, and no registration was assessed |
| A migration loaded successfully and incompletely | Counts were not reconciled by object type and the gap surfaces months later |
| A departure takes knowledge with it | The answer to an impact question lived in a person and now does not |
Regulatory programmes report systems implemented and data migrated. The outcome that matters is whether the questions the function is constantly asked became answerable from the system, quickly, by somebody other than the person who has always known.
| Outcome | How to tell |
|---|---|
| Regulatory data accuracy improved | Completeness is measured against the model and the gap list stays short |
| Submission preparation accelerated | Content and data are assembled from the model rather than gathered each time |
| Global registration visibility strengthened | What is approved where, with dates and pending changes, is one query |
| Manual tracking reduced | The registration and commitment spreadsheets are retired, not shadowing the system |
| Compliance position improved | Audit trail explains why values changed, and submissions can be evidenced as asserted |
| Renewals and variations handled in time | The forward view surfaces them while action is still cheap |
| Operations more efficient | Impact assessment is a query, so the organization stops batching changes to avoid it |
We work with pharmaceutical, biotechnology and medical device organizations on regulatory information: the product and substance model that makes impact questions answerable, registrations held with dates and pending changes, commitments managed as obligations, labelling connected to the markets it applies to, and RIM platform implementation, migration and integration around all of it. Your regulatory affairs function owns every regulatory determination.
CaliberFocus builds the regulatory information layer for pharmaceutical, biotechnology and medical device organizations. We establish the product and substance model that makes impact questions answerable, hold registrations with dates and pending changes, manage commitments as obligations with owners, connect labelling to the markets it applies to, and implement, migrate and integrate RIM platforms around it.
- Product and substance master data treated as the project
- Impact assessment as a query, not a multi-week exercise
- Commitments managed as owned obligations with deadlines
- A forward view of renewals, variations and commitments
Security & Compliance
